CMAC 2018; 20(1)

Vaccination against pneumococcal infections in adults

The following key issues of pneumococcal infection prophylaxis were discussed during the expert council: incidence rates of …

Kozlov R.S., Avdeev S.N., Briko N.I., Bilichenko T.N., Kostinov M.P., Sidorenko S.V., Kharit S.M., Sinopalnikov A.I., Zaitsev A.A., Shubin I.V., Demko I.V., Ignatova G.L., Rachina S.A., Feldblum I.V.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):5-8

10.36488/cmac.2018.1.5-8

PDF

Vaccines for travel and vaccines for adults: moving targets!

This short review provides up-to-date information on vaccination problems for travelers and adults in general, including hepatitis B, …

McIntosh D.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):10-13

10.36488/cmac.2018.1.10-13

PDF

Biological characteristics and virulence of Helicobacter pylori

his review summarizes the most recent data on the biological characteristics of Helicobacter pylori (morphological, cultural, …

Isaeva G.Sh., Valieva R.I.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):14-23

10.36488/cmac.2018.1.14-23

PDF

Ceftazidime-avibactam: new rules for the game against multidrug-resistant gram-negative bacteria

The rapid spread of multidrug-resistant Gram-negative bacteria in hospital settings all over the world makes a demand for the new …

Kozlov R.S., Stetsiouk O.U., Andreeva I.V.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):24-34

10.36488/cmac.2018.1.24-34

PDF

Daptomycin in the treatment of infective endocarditis

This review characterizes daptomycin as a highly effective lipopeptide antibiotic being active against Gram-positive microorganisms, …

Popov D.A.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):35-40

10.36488/cmac.2018.1.35-40

PDF

Antimicrobial resistance of Helicobacter pylori in Smolensk

Objective. To study the antimicrobial resistance of H. pylori to clarithromycin, amoxicillin, metronidazole, levofloxacin, tetracycline …

Dekhnich N.N., Ivanchik N.V., Kozlov R.S., Alimov A.V., Steshits A.S., Kirsov P.P.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):42-48

10.36488/cmac.2018.1.42-48

PDF

Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system

Objective. To determine susceptibility of C. glabrata isolates to anidulafungin, caspofungin and micafungin using the SensititreTM …

Veselov A.V., Vasilyeva N.V., Bogomolova T.S., Raush E.R., Kutsevalova O.Yu., Nizhegorodceva I.A., Petrova L.V., Shmidt N.V., Moskvitina E.N., Sukhorukova M.V., Ivanchik N.V., Kozlov R.S.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):49-54

10.36488/cmac.2018.1.49-54

PDF

Detection of vancomycin-resistant enterococci using chromogenic selective medium

Objective. To detect vancomycin-resistant enterococci (VRE) using chromogenic selective medium CHROMagar™VRE (CHROMagar, France). …

Fyodorova A.V., Klyasova G.A.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):55-61

10.36488/cmac.2018.1.55-61

PDF

Antimicrobial susceptibility testing by broth microdilution method: widely available modification

Objective. To assess the possibility of standard disk application as an antibiotic source for determination of the minimal inhibitory …

Tapalskiy D.V., Bilskiy I.A.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):62-67

10.36488/cmac.2018.1.62-67

PDF

Whole genome sequencing of Mycoplasma hominis strains resistant to ciprofloxacin

In order to determine molecular mechanisms of resistance to ciprofloxacin, clinical isolates of Mycoplasma hominis (2 strains) obtained …

Kolesnikova E.A., Brusnigina N.F., Makhova M.A., Alekseeva A.E.

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):68-72

10.36488/cmac.2018.1.68-72

PDF